Calciject 20 CM Solution for Injection

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Principio attivo:

Boric Acid, Calcium, Magnesium

Commercializzato da:

Norbrook Laboratories Limited

Codice ATC:

QA12AX

INN (Nome Internazionale):

Boric Acid, Calcium, Magnesium

Forma farmaceutica:

Solution for injection

Tipo di ricetta:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Gruppo terapeutico:

Cattle, Sheep

Area terapeutica:

Mineral

Stato dell'autorizzazione:

Expired

Data dell'autorizzazione:

1994-11-15

Scheda tecnica

SPC_139710.DOC
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Calciject 20 CM Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each 400 ml contains 5.92g Calcium (provided by Calcium Gluconate
and
Calcium
Borogluconate)
and
1.85g
magnesium
(provided
by
magnesium hypophosphite). Also contains 3.23% w/v boric acid.
EXCIPIENTS:
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for Injection
A clear colourless to pale yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle.
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For
the
treatment
of
hypocalcaemia
in
cattle
complicated
by
a
deficiency of magnesium in cattle and sheep.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In the treatment of acute hypomagnesaemia, the administration by
appropriate
routes
of
a
solution
with
a
higher
concentration
of
magnesium may also be necessary.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
SPC_139710.DOC
Solutions
for
intravenous
injection
should
be
warmed
to
body
temperature and infused slowly.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Care should be taken to avoid accidental self-injection.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Rapid intravenous injection may result in cardiac arrythmias and in
severely toxaemic cows, collapse and death.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Provided the necessary precautions are observed the product should
be safe for use during pregnancy and lactation.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
SPC_139710.DOC
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Slow intravenous injection.
Subcutaneous injection.
Massage site gently after administration
Cattle
:
400 - 800 ml
Sheep
:
50 - 80 ml
4.10
OVERDOSE
(SYMPTOMS,
EMERGENCY
PROCEDURES,
ANTIDOTES),
IF
NECESSARY
Rapid intravenous injection may resu